Coronavirus Vaccine Update Sinovac. By samantha pearson and luciana magalhaes. In a report in the academic journal science last month, sinovac said its vaccine protected monkeys from infection by the coronavirus.
The brazilian institute conducting the clinical trials has made the announcement. The sinovac vaccine has produced an immune response among volunteers. More than 90% of the 600 healthy volunteers in the phase 2.
Pfizer & biontech bnt162b2 is a messenger rna (mrna) vaccine from.
In september, sinovac's ceo said about 3,000 of its employees had taken their vaccine. 11/11/2020 6:00pm dow jones news. In september, sinovac's ceo said about 3,000 of its employees had taken their vaccine. Associated press | september 24, 2020 9:56 pm